| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 128.88× | 128.88× | 119.04× | 148.88× | 174.45× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.25× | 0.25× | 0.29× | 0.31× | 0.27× | ||
| −4.72× | −4.72× | −0.04× | 0.68× | −4.51× | ||
| −2.54× | −2.54× | −0.04× | 0.90× | −4.69× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 174.45 | 148.88 | 119.04 | 128.88 | 128.88 | |
| Asset Turnover | 0.27 | 0.31 | 0.29 | 0.25 | 0.25 | |
| Cash Conversion (CFO/Net Income) | -4.51 | 0.68 | -0.04 | -4.72 | -4.72 | |
| CFO/EBITDA | -4.69 | 0.90 | -0.04 | -2.54 | -2.54 |